Used primarily in pharmaceutical research as a key intermediate in the synthesis of nicotinic acetylcholine receptor (nAChR) modulators. It plays a significant role in the development of compounds targeting neurological disorders such as Alzheimer's disease, Parkinson's disease, and schizophrenia. Its structural features enable selective interaction with receptor subtypes, making it valuable for optimizing drug candidates with improved efficacy and reduced side effects. Also utilized in the preparation of radiolabeled derivatives for use in receptor binding studies and neuroimaging.